AMLX
Price
$13.88
Change
+$0.40 (+2.97%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.44B
43 days until earnings call
GRI
Price
$2.15
Change
+$0.19 (+9.74%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
4.9M
Interact to see
Advertisement

AMLX vs GRI

Header iconAMLX vs GRI Comparison
Open Charts AMLX vs GRIBanner chart's image
Amylyx Pharmaceuticals
Price$13.88
Change+$0.40 (+2.97%)
Volume$14.34K
Capitalization1.44B
GRI Bio
Price$2.15
Change+$0.19 (+9.74%)
Volume$7.26K
Capitalization4.9M
AMLX vs GRI Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. GRI commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and GRI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (AMLX: $13.48 vs. GRI: $1.95)
Brand notoriety: AMLX and GRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 61% vs. GRI: 22%
Market capitalization -- AMLX: $1.44B vs. GRI: $4.9M
AMLX [@Biotechnology] is valued at $1.44B. GRI’s [@Biotechnology] market capitalization is $4.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileGRI’s FA Score has 2 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • GRI’s FA Score: 2 green, 3 red.
According to our system of comparison, GRI is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while GRI’s TA Score has 6 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • GRI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GRI is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +12.71% price change this week, while GRI (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.44B) has a higher market cap than GRI($4.91M). AMLX has higher P/E ratio than GRI: AMLX (2.81) vs GRI (0.02). AMLX YTD gains are higher at: 256.614 vs. GRI (-86.153). GRI has higher annual earnings (EBITDA): -10.03M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. GRI (5.12M). GRI has less debt than AMLX: GRI (96K) vs AMLX (5.96M). GRI has higher revenues than AMLX: GRI (0) vs AMLX (-249K).
AMLXGRIAMLX / GRI
Capitalization1.44B4.91M29,317%
EBITDA-196.3M-10.03M1,958%
Gain YTD256.614-86.153-298%
P/E Ratio2.810.0213,105%
Revenue-249K0-
Total Cash181M5.12M3,534%
Total Debt5.96M96K6,210%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXGRI
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 6 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 27 days ago
82%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSAN4.770.12
+2.58%
Cosan SA
UHS194.720.56
+0.29%
Universal Health Services
ACNB44.36-0.24
-0.54%
ACNB Corp
SBEV2.19-0.02
-0.90%
Splash Beverage Group
SND2.11-0.06
-2.76%
Smart Sand

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+1.28%
GRI - AMLX
57%
Loosely correlated
-2.50%
SLRX - AMLX
54%
Loosely correlated
+1.91%
LRMR - AMLX
46%
Loosely correlated
-0.89%
RGNX - AMLX
45%
Loosely correlated
-1.43%
OCUL - AMLX
43%
Loosely correlated
+0.41%
More

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with AMLX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-2.50%
AMLX - GRI
57%
Loosely correlated
+1.28%
ATRA - GRI
40%
Loosely correlated
+5.45%
INAB - GRI
40%
Loosely correlated
-2.84%
SNSE - GRI
38%
Loosely correlated
+2.01%
SLRX - GRI
34%
Loosely correlated
+1.91%
More